Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-05 Sale | 2025-12-08 1:56 pm | Metagenomi Inc. | MGX | Thomas Brian C. Director | 3,830 | $1.7719 | $6,786 | 2,510,960 (Direct) | View |
| 2025-12-05 Sale | 2025-12-08 1:51 pm | Metagenomi Inc. | MGX | Wein Matthew See Remarks | 199 | $1.7719 | $353 | 115,031 (Direct) | View |
| 2025-12-05 Sale | 2025-12-08 1:49 pm | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 1,576 | $1.7719 | $2,793 | 188,956 (Direct) | View |
| 2025-12-05 Sale | 2025-12-08 1:38 pm | Metagenomi Inc. | MGX | Irish Jian Chief Executive Officer | 1,602 | $1.7719 | $2,839 | 563,839 (Direct) | View |
| 2025-09-05 Sale | 2025-12-01 7:34 pm | Metagenomi Inc. | MGX | Thomas Brian C. Director | 2,701 | $1.81 | $4,889 | 2,514,790 (Direct) | View |
| 2025-09-05 Sale | 2025-12-01 7:32 pm | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 1,576 | $1.81 | $2,853 | 190,532 (Direct) | View |
| 2025-09-05 Sale | 2025-12-01 7:28 pm | Metagenomi Inc. | MGX | Irish Jian Chief Executive Officer | 1,602 | $1.81 | $2,900 | 790,441 (Direct) | View |
| 2025-09-05 Sale | 2025-12-01 6:37 pm | Metagenomi Inc. | MGX | Wein Matthew See Remarks | 199 | $1.81 | $360 | 115,230 (Direct) | View |
| 2025-06-06 Sale | 2025-06-09 7:04 pm | Metagenomi Inc. | MGX | Wein Matthew See Remarks | 199 | $1.75 | $348 | 16,693 (Direct) | View |
| 2025-06-06 Sale | 2025-06-09 6:57 pm | Metagenomi Inc. | MGX | Noonberg Sarah B. Chief Medical Officer | 5,239 | $1.75 | $9,168 | 109,135 (Direct) | View |
| 2025-06-06 Sale | 2025-06-09 6:54 pm | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 1,576 | $1.75 | $2,758 | 72,108 (Direct) | View |
| 2025-06-06 Sale | 2025-06-09 6:50 pm | Metagenomi Inc. | MGX | Thomas Brian C. Chief Executive Officer | 10,785 | $1.75 | $18,874 | 2,517,491 (Direct) | View |
| 2025-06-06 Sale | 2025-06-09 6:20 pm | Metagenomi Inc. | MGX | Irish Jian See Remarks | 6,390 | $1.75 | $11,183 | 315,543 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 4:38 pm | Metagenomi Inc. | MGX | Wein Matthew See Remarks | 930 | $1.8748 | $1,744 | 9,467 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 4:36 pm | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 1,808 | $1.8748 | $3,390 | 59,684 (Direct) | View |
| 2024-12-05 Sale | 2024-12-06 4:24 pm | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 1,559 | $1.86 | $2,900 | 61,492 (Direct) | View |
| 2024-09-05 Sale | 2024-09-06 5:14 pm | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 6,265 | $2.88 | $18,043 | 63,051 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-01 Option Award | 2025-12-01 7:32 pm | N/A N/A | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 120,000 | $1.6 | 190,532 (Direct) | View |
| 2025-12-01 Option Award | 2025-12-01 7:28 pm | N/A N/A | Metagenomi Inc. | MGX | Irish Jian Chief Executive Officer | 248,500 | $1.6 | 790,441 (Direct) | View |
| 2025-12-01 Option Award | 2025-12-01 7:28 pm | N/A 2035-11-30 | Metagenomi Inc. | MGX | Irish Jian Chief Executive Officer | 225,000 | $0 | 790,441 (Direct) | View |
| 2025-12-01 Option Award | 2025-12-01 6:37 pm | N/A N/A | Metagenomi Inc. | MGX | Wein Matthew See Remarks | 96,000 | $1.6 | 115,230 (Direct) | View |
| 2025-09-02 Option Award | 2025-09-02 4:44 pm | N/A 2035-09-01 | Metagenomi Inc. | MGX | Reid Laurence Director | 42,000 | $0 | 42,000 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 4:43 pm | N/A 2035-06-09 | Metagenomi Inc. | MGX | Eckhardt Juergen Director | 21,000 | $0 | 21,000 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 4:36 pm | N/A 2035-06-09 | Metagenomi Inc. | MGX | Dere Willard H Director | 21,000 | $0 | 21,000 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 4:33 pm | N/A 2035-06-09 | Metagenomi Inc. | MGX | BJERKHOLT ERIC Director | 8,572 | $0 | 8,572 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 11:58 am | N/A 2035-03-31 | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 98,000 | $0 | 157,684 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 11:58 am | N/A 2035-03-31 | Metagenomi Inc. | MGX | Thomas Brian C. Chief Executive Officer | 228,000 | $0 | 2,724,276 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 11:57 am | N/A 2035-03-31 | Metagenomi Inc. | MGX | Irish Jian See Remarks | 163,000 | $0 | 818,898 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 11:57 am | N/A 2035-03-31 | Metagenomi Inc. | MGX | Wein Matthew See Remarks | 52,025 | $0 | 61,492 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 11:56 am | N/A 2035-03-31 | Metagenomi Inc. | MGX | Noonberg Sarah B. Chief Medical Officer | 98,000 | $0 | 198,374 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 4:24 pm | N/A 2035-02-02 | Metagenomi Inc. | MGX | BJERKHOLT ERIC Director | 42,000 | $0 | 42,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 9:10 pm | N/A 2034-03-31 | Metagenomi Inc. | MGX | Irish Jian See Remarks | 366,779 | $0 | 952,206 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 9:08 pm | N/A 2034-03-31 | Metagenomi Inc. | MGX | Eckhardt Juergen Director | 78,636 | $0 | 78,636 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:59 pm | N/A 2034-03-31 | Metagenomi Inc. | MGX | Borges Luis Chief Scientific Officer | 360,766 | $0 | 360,766 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:57 pm | N/A 2034-03-31 | Metagenomi Inc. | MGX | Wein Matthew See Remarks | 54,114 | $0 | 54,114 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:52 pm | N/A 2034-03-31 | Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer | 360,766 | $0 | 360,766 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:47 pm | N/A 2034-03-31 | Metagenomi Inc. | MGX | Noonberg Sarah B. Chief Medical Officer | 300,638 | $0 | 343,249 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:44 pm | N/A 2034-03-31 | Metagenomi Inc. | MGX | Bernales Sebastian Director | 78,636 | $0 | 78,636 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:40 pm | N/A 2034-03-31 | Metagenomi Inc. | MGX | Harnest Simon See Remarks | 60,127 | $0 | 171,239 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:18 pm | N/A 2034-03-31 | Metagenomi Inc. | MGX | Delaney Simren See Remarks | 36,076 | $0 | 123,037 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:11 pm | N/A 2034-03-31 | Metagenomi Inc. | MGX | Dere Willard H Director | 78,636 | $0 | 78,636 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:00 pm | N/A 2034-03-31 | Metagenomi Inc. | MGX | Thomas Brian C. Chief Executive Officer | 619,315 | $0 | 2,996,599 (Direct) | View |